CN Patent

CN121335697A — 包括苯巴比妥的药物口服固体剂型及其制造和使用方法

Assigned to Jinnas Life Sciences Co · Expires 2026-01-13 · 0y expired

What this patent protects

本文公开了包括苯巴比妥和苯巴比妥盐中的至少一种的药物口服固体剂型以及制造和使用该药物口服固体剂型的方法。

USPTO Abstract

本文公开了包括苯巴比妥和苯巴比妥盐中的至少一种的药物口服固体剂型以及制造和使用该药物口服固体剂型的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN121335697A
Jurisdiction
CN
Classification
—
Expires
2026-01-13
Drug substance claim
No
Drug product claim
No
Assignee
Jinnas Life Sciences Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.